Contact
Score Calculators
Publications
Advancing knowledge in chronic liver disease through evidence-based research.
AbstractsPublication policy

Showing 10 of 274 papers

Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis

Markwardt D, Holdt L, Steib C, Benesic A, Bendtsen F, Bernardi M, Moreau R, Teupser D, Wendon J, Nevens F, Trebicka J, Garcia E, Pavesi M, Arroyo V, Gerbes AL.

Hepatology 2017, 66(4): 1232—1241

DOI: 10.1002/hep.29290

Microalbuminuria, systemic inflammation, and multiorgan dysfunction in decompensated cirrhosis: Evidence for a nonfunctional mechanism of hepatorenal syndrome

Arroyo V.

Hepatol Int 2017, 11(3): 242—244

DOI: 10.1007/s12072-017-9784-3

Impact of genetic variation in the vasopressin 1a receptor on the development of organ failure in patients admitted for acute decompensation of liver cirrhosis

Kerbert AJ, Schaapman JJ, van der Reijden JJ, Amorós Navarro À, McCormick A, van Hoek B, Arroyo V, Ginès P, Jalan R, Vargas V, Stauber R, Verspaget HW, Coenraad MJ; CANONIC Study Investigators of the EASL-CLIF Consortium.

Eur J Gastroenterol Hepatol, 29(5): 535—538

DOI: 10.1097/MEG.0000000000000834

Portal vein thrombosis in patients with cirrhosis

von Köckritz L, De Gottardi A, Trebicka J, Praktiknjo M.

Gastroenterol Rep (Oxf) 2017, 5(2): 148–156

DOI: 10.1093/gastro/gox014

Rationale for the use of statins in liver disease

Schierwagen R, Uschner FE, Magdaleno F, Klein S, Trebicka J.

Am J Physiol Gastrointest Liver Physiol 2017, 312(5): G407–G412

DOI: 10.1152/ajpgi.00441.2016

Acute-on-chronic liver failure: An update

Hernaez R, Solà E, Moreau R, Ginès P.

Gut 2017, 66(3): 541–553

DOI: 10.1136/gutjnl-2016-312670

Diagnosis and prognosis of acute on chronic liver failure (ACLF) in cirrhosis

Arroyo V, Moreau R.

J Hepatol 2017, 66(2): 451–453

DOI: 10.1016/j.jhep.2016.10.012

Polymorphisms in the IL-1 gene cluster influence systemic inflammation in patients at risk for acute-on-chronic liver failure

Alcaraz-Quiles J, Titos E, Casulleras M, Pavesi M, López-Vicario C, Rius B, Lopategi A, de Gottardi A, Graziadei I, Gronbaek H, Ginès P, Bernardi M, Arroyo V, Clària J.

Hepatology 2017, 65(1): 202–216

DOI: 10.1002/hep.28896

The acute-on-chronic liver failure syndrome, or when the innate immune system goes astray

Clària J, Arroyo V, Moreau R.

J Immunol 2016, 197(10): 3755–3761

DOI: 10.4049/jimmunol.1600818

Treatment with non-selective beta blockers is associated with reduced severity of systemic inflammation and improved survival of patients with acute-on-chronic liver failure

Mookerjee RP, Pavesi M, Thomsen KL, Mehta G, Macnaughtan J, Bendtsen F, Coenraad M, Sperl J, Gines P, Moreau R, Arroyo V, Jalan R; CANONIC Study Investigators of the EASL-CLIF Consortium

J Hepatol 2016, 64(3): 574–582

DOI: 10.1016/j.jhep.2015.10.018

Registered office

European Foundation for the Study of
Chronic Liver Failure
Avinguda Diagonal 477, 11th floor
08036 Barcelona, Spain

Legal

Contact us

Tel: +34 93 227 14 00
Email: Send us an email

© European Foundation for the Study of Chronic Liver Failure 2024